Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | %Female (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Critical Reviews in Oncogenesis | journal | 2.858 Q1 | 57 | 11 | 51 | 3199 | 200 | 51 | 3.81 | 290.82 | 14.29 | |
2 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 4 | 22 | 526 | 17 | 22 | 1.00 | 131.50 | 28.57 | ||
3 | Advances in Oncobiology | book series | 0.115 Q4 | 3 | 23 | 16 | 2718 | 1 | 15 | 0.00 | 118.17 | 22.58 | |
4 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 14 | 28 | 1509 | 2 | 28 | 0.00 | 107.79 | 18.06 | ||
5 | Cancer and Metastasis Reviews | journal | 1.705 Q1 | 167 | 38 | 114 | 3783 | 384 | 113 | 2.49 | 99.55 | 23.46 | |
6 | Sub-Cellular Biochemistry | journal | 0.780 Q2 | 81 | 15 | 115 | 1397 | 169 | 115 | 1.54 | 93.13 | 12.50 | |
7 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 10 | 182 | 0 | 10 | 0.00 | 91.00 | 16.67 | ||
8 | Cancer Treatment and Research | journal | 0.331 Q3 | 65 | 44 | 290 | 3998 | 224 | 290 | 0.51 | 90.86 | 22.08 | |
9 | Advances in Cancer Research | journal | 10.730 Q1 | 109 | 18 | 51 | 1536 | 781 | 51 | 16.83 | 85.33 | 25.00 | |
10 | Recent Results in Cancer Research | book series | 0.345 Q3 | 63 | 10 | 224 | 804 | 182 | 224 | 0.75 | 80.40 | 27.78 | |
11 | Pathogenesis | journal | 8 | 6 | 0 | 417 | 0 | 0 | 0.00 | 69.50 | 11.76 | ||
12 | Seminars in Cancer Biology | journal | 3.871 Q1 | 179 | 48 | 93 | 3287 | 503 | 89 | 5.82 | 68.48 | 22.58 | |
13 | Drug Resistance Updates | journal | 0.642 Q2 | 132 | 51 | 56 | 3305 | 109 | 48 | 1.95 | 64.80 | 24.73 | |
14 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.067 Q1 | 112 | 41 | 115 | 2508 | 252 | 114 | 2.13 | 61.17 | 41.18 | |
15 | Hematological Oncology | journal | 0.369 Q3 | 54 | 12 | 62 | 715 | 52 | 62 | 0.76 | 59.58 | 17.65 | |
16 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.236 Q3 | 50 | 142 | 45 | 8141 | 25 | 45 | 1.17 | 57.33 | 0.00 | |
17 | Molecular Cancer Research | journal | 3.158 Q1 | 153 | 87 | 424 | 4702 | 1996 | 424 | 4.76 | 54.05 | 42.61 | |
18 | Neuro-Oncology | journal | 163 | 29 | 0 | 1554 | 0 | 0 | 0.00 | 53.59 | 22.73 | ||
19 | Progress in Experimental Tumor Research | book series | 20 | 25 | 0 | 1312 | 0 | 0 | 0.00 | 52.48 | 20.90 | ||
20 | Differentiation | journal | 1.195 Q1 | 107 | 43 | 131 | 2211 | 299 | 131 | 2.31 | 51.42 | 32.72 | |
21 | Apoptosis : an international journal on programmed cell death | journal | 0.700 Q2 | 128 | 48 | 130 | 2463 | 202 | 130 | 1.44 | 51.31 | 36.31 | |
22 | Acta Oncologica, Supplement | journal | 0.335 Q3 | 8 | 12 | 4 | 598 | 2 | 4 | 2.00 | 49.83 | 19.23 | |
23 | Oncogene | journal | 4.649 Q1 | 370 | 924 | 2088 | 45771 | 13820 | 2087 | 6.41 | 49.54 | 34.73 | |
24 | Endocrine-Related Cancer | journal | 0.326 Q3 | 146 | 63 | 110 | 3043 | 93 | 108 | 0.81 | 48.30 | 34.71 | |
25 | Angiogenesis | journal | 0.572 Q2 | 101 | 39 | 49 | 1873 | 65 | 49 | 1.33 | 48.03 | 27.06 | |
26 | Neoplasia | journal | 144 | 61 | 0 | 2847 | 0 | 0 | 0.00 | 46.67 | 26.50 | ||
27 | Seminars in Radiation Oncology | journal | 0.737 Q2 | 103 | 63 | 125 | 2769 | 205 | 119 | 0.97 | 43.95 | 23.64 | |
28 | Cancer Gene Therapy | journal | 1.418 Q1 | 99 | 62 | 133 | 2683 | 585 | 132 | 4.18 | 43.27 | 28.95 | |
29 | Carcinogenesis | journal | 1.641 Q1 | 223 | 344 | 1092 | 14750 | 4267 | 1085 | 3.96 | 42.88 | 29.02 | |
30 | Advances in Biological Regulation | journal | 1.181 Q1 | 69 | 23 | 67 | 957 | 132 | 67 | 1.91 | 41.61 | 31.40 | |
31 | Experimental Hematology | journal | 0.335 Q3 | 129 | 203 | 2293 | 8446 | 1379 | 2267 | 0.61 | 41.61 | 34.27 | |
32 | Molecular Carcinogenesis | journal | 1.356 Q1 | 107 | 108 | 288 | 4467 | 766 | 287 | 2.54 | 41.36 | 35.02 | |
33 | Cancer Investigation | journal | 0.641 Q2 | 93 | 95 | 267 | 3923 | 370 | 224 | 1.18 | 41.29 | 35.34 | |
34 | Oncology Research | journal | 0.732 Q2 | 76 | 117 | 355 | 4765 | 690 | 352 | 2.10 | 40.73 | 30.16 | |
35 | Journal of Immunotherapy | journal | 1.340 Q1 | 106 | 49 | 94 | 1950 | 278 | 93 | 2.79 | 39.80 | 28.40 | |
36 | Current Problems in Cancer | journal | 0.575 Q2 | 47 | 14 | 29 | 544 | 41 | 28 | 2.29 | 38.86 | 0.00 | |
37 | Cancer Immunology, Immunotherapy | journal | 0.845 Q2 | 136 | 83 | 282 | 3209 | 698 | 280 | 2.39 | 38.66 | 32.50 | |
38 | Current Opinion in Oncology | journal | 0.942 Q1 | 104 | 106 | 325 | 4053 | 627 | 306 | 1.97 | 38.24 | 24.18 | |
39 | Medical Oncology | journal | 0.405 Q3 | 90 | 43 | 114 | 1641 | 94 | 111 | 0.73 | 38.16 | 32.16 | |
40 | Invasion and Metastasis | journal | 0.555 Q2 | 31 | 11 | 76 | 419 | 102 | 76 | 0.96 | 38.09 | 31.25 | |
41 | Leukemia | journal | 1.100 Q1 | 219 | 355 | 1318 | 13440 | 3270 | 1187 | 2.28 | 37.86 | 32.83 | |
42 | Nutrition and Cancer | journal | 0.968 Q1 | 130 | 94 | 290 | 3534 | 756 | 289 | 2.34 | 37.60 | 39.85 | |
43 | Journal of Tumor Marker Oncology | journal | 0.153 Q4 | 9 | 21 | 62 | 784 | 28 | 62 | 0.35 | 37.33 | 37.74 | |
44 | In Vivo | journal | 0.296 | 72 | 90 | 258 | 3341 | 204 | 257 | 0.88 | 37.12 | 26.06 | |
45 | Cancer Research | journal | 4.760 Q1 | 498 | 1001 | 2817 | 37063 | 25224 | 2788 | 8.54 | 37.03 | 30.68 | |
46 | Tumor Targeting | journal | 0.664 Q2 | 10 | 32 | 22 | 1183 | 41 | 21 | 1.86 | 36.97 | 31.07 | |
47 | Clinical and Experimental Metastasis | journal | 0.858 Q2 | 109 | 103 | 193 | 3797 | 462 | 193 | 2.24 | 36.86 | 24.15 | |
48 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.794 Q2 | 35 | 17 | 61 | 623 | 140 | 59 | 2.51 | 36.65 | 18.52 | |
49 | Cancer Epidemiology | journal | 0.427 Q3 | 86 | 66 | 195 | 2388 | 207 | 195 | 0.91 | 36.18 | 28.26 | |
50 | European Journal of Cancer | journal | 0.934 Q2 | 245 | 328 | 1487 | 11640 | 3463 | 1264 | 1.96 | 35.49 | 26.88 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®